regulatory updates for mRNA therapeutics globally

Regulations for mRNA products are evolving as the market for mRNA expands.

Medicinal products that use messenger RNA (mRNA) as an active substance have great potential for treating many conditions. They offer an adaptable response to changing diseases and...

According to the World Health Organization (WHO), there is no formal regulatory guidance specifically for mRNA-based vaccines. However, the WHO provides information and regulatory ...

In this GEN webinar, a panel of industry experts will explore the evolution of mRNA technology and the innovations that are driving the conversation around manufacturing setups and...

Even after the runaway success of mRNA vaccines against COVID-19, the pathway to approval for upcoming would-be mRNA therapeutics has yet to be laid out.

Over the past two years, Operation Warp Speed brought mRNA-based vaccines into the spotlight, as organizations like Moderna and Pfizer/BioNTech raced to develop a COVID-19 vaccine....

DataM Intelligence has released an in depth research report on mRNA Vaccines Market Size 2025 This report delivers power packed insights into key growth drivers market segmentation...

The report "mRNA Therapeutics Market by Product (Vaccines, Drugs), Application (Oncology, Rare Diseases, Infectious Diseases, Other Applications), End User (Hospitals & Clinics, Re...

Propelled by the SARS-CoV-2 vaccines, a new era of mRNA medicines is just beginning to unfold. New vaccines and therapies are on their way.

Moderna and Pfizer/BioNTech have secured formula updates to existing mRNA Covid-19 vaccines.


Related Content From The Pandipedia